[Skip to Content]
[Skip to Content Landing]
September 1974

Azathioprine Therapy in Incomplete Behçet Syndrome

Author Affiliations

From the Department of Medicine, Division of Dermatology, Sunnybrook Medical Centre, University of Toronto, Toronto.

Arch Dermatol. 1974;110(3):432-434. doi:10.1001/archderm.1974.01630090066014

A patient with relapsing severe orogenital aphthae and cutaneous ulcers consistent with incomplete Behçet syndrome failed to respond to conventional treatment, including continuous orally administered corticosteroid therapy in moderate doses. Having spent little time out of the hospital in the previous two years, she was placed on a regimen of azathioprine, 150 mg daily, in April, 1972. Since September, 1972, she has been free of disease except for occasional short-lived mouth ulcers while her prednisone dose was gradually reduced to 5 mg daily. No serious toxic side effects have developed after 21 months on this regimen.